EIDO Healthcare has been acquired by Radar Healthcare

EIDO Healthcare has been successfully acquired by Radar Healthcare, a leading provider of digital risk management and quality compliance software.

Together, EIDO and Radar, two established providers of healthcare solutions, will combine their expertise to deliver best-in-class tools for organizations across the health and care landscape, supporting safer and more effective care. By uniting Radar’s innovative technology with EIDO’s trusted informed consent solutions, the combined organization is well-positioned to accelerate growth and enhance its offerings for customers in health and care markets worldwide. This announcement follows a significant investment in Radar last year from Marlin Equity Partners.

EIDO is a trusted provider of digital consent and patient information solutions, specializing in creating clear, accurate and accessible content to support informed consent in healthcare. With decades of experience, EIDO helps healthcare providers deliver safe, effective care by ensuring patients have the information they need to make informed decisions about their treatment. Its modular digital informed consent solution supports deployment into the patient pathway, either as standalone modules or as a complete solution. Known for its commitment to quality and innovation, EIDO works with healthcare organizations worldwide to empower both patients and clinicians in achieving better outcomes.

Radar, a Marlin portfolio company, empowers health and social care organizations to make a meaningful impact on patient safety and quality of care. By combining digital innovation with real-world healthcare expertise, Radar enables providers not only to meet regulatory standards but also to proactively identify trends, prevent incidents and drive continuous improvement. Designed for flexibility and adaptability, and with a deep understanding of the daily challenges in health and care, Radar is dedicated to evolving alongside the industry, delivering a system that is valued for its role in shaping safer, more effective care.

Oaklins Cavendish, one of Oaklins’ member firms in the UK, advised on the sale of EIDO to Radar.

Servicio

M&A sell-side

Partes

“Selling a business that you’ve built over decades is a major milestone, and choosing the right advisors is critical. Oaklins Cavendish exceeded our expectations at every stage of the process. Their deep understanding of the healthcare technology sector, strategic guidance and tireless dedication ensured that we achieved an outstanding outcome. They struck a balance between advocating for the best value for our business while providing honest and pragmatic advice when required. Best of all, they are simply a great group of people to work with. Thanks to their expertise, we found the perfect partner in Marlin Private Equity to take EIDO Healthcare forward.”

Owain Tudor

Founder, EIDO Healthcare